Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

E-ISSN： 1873-4286|14|11|1058-1077

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.11, 2008-04, pp. : 1058-1077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma

By Sfoungaristos Stavros Giannitsas Konstantinos Perimenis Petros

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 533-547

Informa Healthcare

Access to resources Recommend Favorite

VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 164-168

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiogenesis in renal cell carcinoma

By Posadas Edwin M Limvorasak Suwicha Sharma Shaleekha Figlin Robert A

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2221-2236

Informa Healthcare

Access to resources Recommend Favorite

Targeting Angiogenesis in Renal Cell Carcinoma

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 349-358

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Sarcomas: Novel Biological Agents and Future Perspectives

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 937-949

Bentham Science Publishers

Access to resources Recommend Favorite